Suppr超能文献

呼吸复合体和组织谱系驱动肿瘤线粒体DNA中的复发性突变。

Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.

作者信息

Gorelick Alexander N, Kim Minsoo, Chatila Walid K, La Konnor, Hakimi A Ari, Berger Michael F, Taylor Barry S, Gammage Payam A, Reznik Ed

机构信息

Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Nat Metab. 2021 Apr;3(4):558-570. doi: 10.1038/s42255-021-00378-8. Epub 2021 Apr 8.

Abstract

Mitochondrial DNA (mtDNA) encodes protein subunits and translational machinery required for oxidative phosphorylation (OXPHOS). Using repurposed whole-exome sequencing data, in the present study we demonstrate that pathogenic mtDNA mutations arise in tumours at a rate comparable to those in the most common cancer driver genes. We identify OXPHOS complexes as critical determinants shaping somatic mtDNA mutation patterns across tumour lineages. Loss-of-function mutations accumulate at an elevated rate specifically in complex I and often arise at specific homopolymeric hotspots. In contrast, complex V is depleted of all non-synonymous mutations, suggesting that impairment of ATP synthesis and mitochondrial membrane potential dissipation are under negative selection. Common truncating mutations and rarer missense alleles are both associated with a pan-lineage transcriptional programme, even in cancer types where mtDNA mutations are comparatively rare. Pathogenic mutations of mtDNA are associated with substantial increases in overall survival of colorectal cancer patients, demonstrating a clear functional relationship between genotype and phenotype. The mitochondrial genome is therefore frequently and functionally disrupted across many cancers, with major implications for patient stratification, prognosis and therapeutic development.

摘要

线粒体DNA(mtDNA)编码氧化磷酸化(OXPHOS)所需的蛋白质亚基和翻译机制。在本研究中,我们利用重新利用的全外显子测序数据证明,肿瘤中致病性mtDNA突变的出现频率与最常见的癌症驱动基因相当。我们确定氧化磷酸化复合物是塑造跨肿瘤谱系的体细胞mtDNA突变模式的关键决定因素。功能丧失突变尤其在复合物I中以较高频率积累,且常出现在特定的同聚物热点区域。相比之下,复合物V没有所有非同义突变,这表明ATP合成受损和线粒体膜电位耗散处于负选择之下。常见的截断突变和罕见的错义等位基因都与一个泛谱系转录程序相关,即使在mtDNA突变相对罕见的癌症类型中也是如此。mtDNA的致病性突变与结直肠癌患者总生存率的显著提高相关,表明基因型与表型之间存在明确的功能关系。因此,线粒体基因组在许多癌症中经常且在功能上受到破坏,这对患者分层、预后和治疗发展具有重要意义。

相似文献

3
Mitochondrial DNA mutations in Malaysian female breast cancer patients.马来西亚女性乳腺癌患者的线粒体 DNA 突变。
PLoS One. 2020 May 22;15(5):e0233461. doi: 10.1371/journal.pone.0233461. eCollection 2020.
4
Mitochondrial DNA mutations in pancreatic cancer.胰腺癌中的线粒体DNA突变。
Int J Gastrointest Cancer. 2006;37(2-3):57-64. doi: 10.1007/s12029-007-0008-2.
10
Somatic mutations of the mitochondrial genome in human breast cancers.人类乳腺癌中线粒体基因组的体细胞突变。
Genes Chromosomes Cancer. 2011 Oct;50(10):800-11. doi: 10.1002/gcc.20901. Epub 2011 Jul 11.

引用本文的文献

4
MIA40 suppresses cell death induced by apoptosis-inducing factor 1.MIA40抑制由凋亡诱导因子1诱导的细胞死亡。
EMBO Rep. 2025 Apr;26(7):1835-1862. doi: 10.1038/s44319-025-00406-8. Epub 2025 Mar 7.
6
Mitochondrial genome diversity drives heterogeneity in HCC.线粒体基因组多样性驱动肝癌的异质性。
Hepatology. 2025 Jul 1;82(1):12-13. doi: 10.1097/HEP.0000000000001161. Epub 2024 Nov 12.
10
Quantifying constraint in the human mitochondrial genome.量化人类线粒体基因组中的约束。
Nature. 2024 Nov;635(8038):390-397. doi: 10.1038/s41586-024-08048-x. Epub 2024 Oct 16.

本文引用的文献

1
Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy.靶向代谢可塑性和灵活性动态用于癌症治疗。
Cancer Discov. 2020 Dec;10(12):1797-1807. doi: 10.1158/2159-8290.CD-20-0844. Epub 2020 Nov 2.
3
Mitochondrial ubiquinol oxidation is necessary for tumour growth.线粒体泛醇氧化对于肿瘤生长是必需的。
Nature. 2020 Sep;585(7824):288-292. doi: 10.1038/s41586-020-2475-6. Epub 2020 Jul 8.
7
Mitochondrial DNA: the overlooked oncogenome?线粒体 DNA:被忽视的致癌基因组?
BMC Biol. 2019 Jul 8;17(1):53. doi: 10.1186/s12915-019-0668-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验